Bristol Myers Squibb to announce Q2 2026 results on July 30
Bristol Myers Squibb is set to release its Q2 2026 financial results on July 30, 2026, followed by an executive conference call at 8:15 a.m. ET. The company will provide live webcast access via its Investor Relations website, with a replay available shortly after the event.
*this image is generated using AI for illustrative purposes only.
Bristol Myers Squibb will announce its financial results for the second quarter of 2026 on July 30, 2026. Company executives will review the financial performance with the investment community during a conference call scheduled to begin at 8:15 a.m. ET. Investors and the general public are invited to listen to a live audio webcast of the proceedings.
Materials related to the conference call will be accessible on the company's Investor Relations website prior to the start of the event. A replay of the webcast will be available approximately three hours after the conclusion of the call.
Key Event Details
| Event | Date | Time |
|---|---|---|
| Q2 2026 Results Announcement | July 30, 2026 | 8:15 a.m. ET |
| Live Webcast Access | July 30, 2026 | 8:15 a.m. ET |
| Webcast Replay Availability | July 30, 2026 | ~3 hours post-call |
Bristol Myers Squibb focuses on discovering, developing, and delivering innovative medicines for patients with serious diseases. Further information regarding the company and its financial updates can be found on its official website.
What key performance indicators will investors focus on during the Q2 2026 earnings call?
How might Bristol Myers Squibb's pipeline developments influence its financial outlook for the remainder of 2026?
What impact could macroeconomic conditions have on the company's revenue projections?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
